Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?

PURPOSE: Adjuvant FOLFOX (5-fluorouracil and oxaliplatin) chemotherapy benefits stage III colon cancer patients. However, it still results in side effects and increased cost. Reducing cycles had been thought to decrease these problems. This retrospective study aimed to find the appropriate number of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Springerplus
Hauptverfasser: Tsai, Yi-Jian, Lin, Jen-Kou, Chen, Wei-Shone, Jiang, Jeng-Kai, Teng, Hao-Wei, Yen, Chueh-Chuan, Lin, Tzu-chen, Yang, Shung-Haur
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2016
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4980863/
https://ncbi.nlm.nih.gov/pubmed/27563513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-2976-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge